Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02693509
Other study ID # GWTG01
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 2005
Est. completion date January 2040

Study information

Verified date December 2023
Source American Heart Association
Contact Kelly Burlison, RN, BSN
Phone 2147062237
Email kelly.burlison@heart.org
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Get With The Guidelines-Heart Failure is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge.


Description:

Get With The Guidelines-Heart Failure was initiated in 2005 with over 500 U.S. hospitals participating is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge. Peer-reviewed research(with over 35 manuscripts) has demonstrated that through participating in Get With The Guidelines-Heart Failure, hospitals will provide equitable care (regardless of race, ethnicity, age, or gender), the importance of scheduled physician follow-up after heart failure hospital discharge, the value in device-support as necessary for the acute heart failure patient, and many other significant findings. Achievement measures tracked through Get With The Guidelines-Heart Failure: - Angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) at discharge - Evidence-based specific beta blockers - Measure left ventricular function - Post-discharge appointment for heart failure patients Quality Measures tracked through Get With The Guidelines-Heart Failure: - Mineralocorticoid receptor antagonist at discharge - Aldosterone antagonist at discharge - Anticoagulation for atrial fibrillation - Hydralazine nitrate at discharge - DVT prophylaxis - CRT-D or CRT-P placed or prescribed at discharge - ICD counseling, or ICD placed or prescribed at discharge - Influenza vaccination during flu season - Pneumococcal vaccination - Follow-up visit within 7 days or less - Lab monitoring follow-up - SGLT-2 inhibitor at discharge - Defect-free care for quadruple therapy medication for patients with heart failure with reduced ejection fraction - Direct-acting oral anticoagulant at discharge for non-valvular atrial fibrillation or atrial flutter patients Additional measures collected by Get With The Guidelines-Heart Failure can be viewed at: http://www.heart.org/idc/groups/heart-public/@wcm/@private/@hcm/@gwtg/documents/downloadable/ ucm_310967.pdf


Recruitment information / eligibility

Status Recruiting
Enrollment 128026
Est. completion date January 2040
Est. primary completion date January 2040
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 125 Years
Eligibility Inclusion Criteria: - Patients hospitalized with congestive heart failure. Exclusion Criteria: - Patients who do not have congestive heart failure, - Patients under age of 18, - Patients not admitted as inpatients.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
GWTG Heart Failure program
Evidence based guideline recommended therapies and counseling prior to hospital discharge

Locations

Country Name City State
United States Kelly Burlison Dallas Texas

Sponsors (1)

Lead Sponsor Collaborator
American Heart Association

Country where clinical trial is conducted

United States, 

References & Publications (2)

American Academy of Family Physicians; American Academy of Hospice and Palliative Medicine; American Nurses Association; American Society of Health-System Pharmacists; Heart Rhythm Society; Society of Hospital Medicine; Bonow RO, Ganiats TG, Beam CT, Blake K, Casey DE Jr, Goodlin SJ, Grady KL, Hundley RF, Jessup M, Lynn TE, Masoudi FA, Nilasena D, Pina IL, Rockswold PD, Sadwin LB, Sikkema JD, Sincak CA, Spertus J, Torcson PJ, Torres E, Williams MV, Wong JB; ACCF/AHA Task Force on Performance Measures; Peterson ED, Masoudi FA, DeLong E, Erwin JP 3rd, Fonarow GC, Goff DC Jr, Grady KL, Green LA, Heidenreich PA, Jenkins KJ, Loth A, Shahian DM. ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. J Am Coll Cardiol. 2012 May 15;59(20):1812-32. doi: 10.1016/j.jacc.2012.03.013. Epub 2012 Apr 23. No abstract available. — View Citation

Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239. doi: 10.1016/j.jacc.2013.05.019. Epub 2013 Jun 5. No abstract available. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary 30 day readmission rate Percent of index encounters where there is a readmission within 30 days 30 days post discharge from hospital
Primary 60 day readmission rate Percent of index encounters where there is a readmission within 60 days 60 days post discharge from hospital
Primary 90 day readmission rate Percent of index encounters where there is a readmission within 90 days 90 days post discharge from hospital
See also
  Status Clinical Trial Phase
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy